Top Section/Ad
Top Section/Ad
Most recent
French biotech seeks to accelerate cancer vaccine program
Payment processor's shares dropped to new low on Thursday
More articles/Ad
More articles/Ad
More articles
-
More dilution to come -
Rights issue will allow shareholders to buy shares at a 99.4% discount to Wednesday’s closing price
-
Moroccan investor to sell 11.3% of bank in fully marketed offering, after replacing Crédit Agricole as majority shareholder
-
Swiss asset manager’s anchor investor to underwrite the rights issue, two Norwegian companies do block trades
-
Over half of deal was spoken for at launch
-
Investment firms JRJ Group, Trilantic Capital and BXR Group Holdings are the sellers
